Stock Detail
PSIVIDA CORP
Biotechnology
PSDV @ Yahoo Finance | PSDV Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $1.34 | $1.46 | $-0.06 | -4.29% | 0.00 | $1.40 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $1.40 | $1.33 | 146,020 | 27.88M | 93,536.5 | -3.44 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 1.51 | 1.43 | 1.38 | 1.30 | 1.25 |
Stock Profile
pSivida Limited, through its subsidiaries, engages in the development and commercialization of nanostructured porous silicon, called as BioSilicon for multiple potential applications in animal and human healthcare. BioSilicon functions as a honeycomb structure to retain drugs within the cells and used as a platform technology across various medical applications, including orthopedics, tissue culturing and tissue scaffolds, gene delivery, neural interfacing, and specialized drug delivery. The company develops BrachySil, an injectable BioSilicon structure, which carries 32-phosphorus, a radioactive isotope. It primarily operates in the United Kingdom, Australia, and Singapore. pSivida was founded in 1987 and is headquartered in Perth, Australia.